BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17003085)

  • 1. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
    Welt CK; Gudmundsson JA; Arason G; Adams J; Palsdottir H; Gudlaugsdottir G; Ingadottir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4842-8. PubMed ID: 17003085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.
    Wang JG; Lobo RA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1394-7. PubMed ID: 18230664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes.
    Fitzgerald S; Stamoulis C; Gooding HC; DiVasta AD
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):697-702. PubMed ID: 32889085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
    Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.
    Murphy MK; Hall JE; Adams JM; Lee H; Welt CK
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3878-84. PubMed ID: 16882750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
    Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
    Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
    Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
    Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S; Atakul N; Oncul M; Tuten A; Aydogan B; Seyisoglu H
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations.
    Ladrón de Guevara A; Fux-Otta C; Crisosto N; Szafryk de Mereshian P; Echiburú B; Iraci G; Perez-Bravo F; Sir-Petermann T
    Fertil Steril; 2014 Jun; 101(6):1732-9.e1-2. PubMed ID: 24666752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
    Kim JJ; Hwang KR; Lee D; Kim S; Choi YM
    Hum Reprod; 2024 May; 39(5):1072-1077. PubMed ID: 38514450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.